Turning Point Therapeutics to Participate in Upcoming Virtual Investor Conference

    NEXT STORY
    AXIM® Biotechnologies Files Patent for Virus Binding Recombinant Protein for SARS-CoV-2 (COVID-19) and Begins Manufacturing
    PREV STORY
    [2020-2026] Precision Diagnostics Market Size, Share, Growth, Trends, Revenue, Value, Competitive Landscape, Forecast Report by Fortune Business Insights
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    XBiotech présente des données d’une étude pivot de phase III qui ont démontré une réponse clinique significative de Xilonix™ chez des patients atteints d’un cancer colorectal de stade avancé réfractaires à tout nouveau traitement

    Amélioration de la réponse clinique observée pour plusieurs symptômes associés à la progression de ...

    author_avatar
    NASDAQ Market News

    AnaptysBio to Present at Wedbush PacGrow Healthcare Conference

    SAN DIEGO, Aug. 08, 2017 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq:ANAB), a clinical-stage biotechnology ...

    author_avatar
    NASDAQ Market News

    Five Prime Announces Fourth Quarter and Full Year 2015 Financial Results

    SOUTH SAN FRANCISCO, Calif., March 10, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

    author_avatar
    NASDAQ Market News